Salivary levels of antimicrobial peptides Hnp 1-3, Ll-37 and S100 in Behcet's disease

Archives of Oral Biology

Volumn 57, Issue 6, 2012, Pages 642-646

  Mumcu, Gonca ^a   Cimilli, Hale ^a   Karacayli, Umit ^b   Inanc, Nevsun ^a   Ture Ozdemir, Filiz ^a   Eksioglu Demiralp, Emel ^a   Ergun, Tulin ^a   Direskeneli, Haner ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Beh et disease; Saliva and HNP 1 3

Indexed keywords

ALPHA DEFENSIN; ANTIMICROBIAL CATIONIC PEPTIDE; BIOLOGICAL MARKER; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; DEFENSIN 1; DEFENSIN 2; DEFENSIN 3; PROTEIN S 100;

ADULT; ARTICLE; BEHCET DISEASE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; NONPARAMETRIC TEST; SALIVA;

ADULT; ALPHA-DEFENSINS; ANTIMICROBIAL CATIONIC PEPTIDES; BEHCET SYNDROME; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; S100 PROTEINS; SALIVA; STATISTICS, NONPARAMETRIC;

EID: 84861581930     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2011.11.003     Document Type: Article

References (36)

1. S. Yavuz, G. Ozilhan, Y. Elbir, A. Tolunay, E. Eksioglu-Demiralp, and H. Direskeneli Activation of neutrophils by testosterone in Behcet's disease Clin Exp Rheumatol 25 July-August (4 Suppl. 45) 2007 S46 S51
2. H. Direskeneli Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51 Ann Rheum Dis 60 November (11) 2001 996 1002
3. G. Atalay, E. Eksioglu-Demiralp, T. Akoglu, and H. Direskeneli The effects of nitric oxide donors and inhibitors on neutrophil functions in Behcet's disease Clin Exp Rheumatol 20 July-August (4 Suppl. 26) 2002 S17 S20
4. E. Eksioglu-Demiralp, H. Direskeneli, A. Kibaroglu, S. Yavuz, T. Ergun, and T. Akoglu Neutrophil activation in Behcet's disease Clin Exp Rheumatol 19 September-October (5 Suppl. 24) 2001 S19 S24 [Comparative study]
5. F. Gogus, I. Fresko, Y. Elbir, E. Eksioglu-Demiralp, and H. Direskeneli Oxidative burst response to monosodium urate crystals in patients with Behcet's syndrome Clin Exp Rheumatol 23 July-August (4 Suppl. 38) 2005 S81 S85
6. S. Pay, I. Simsek, H. Erdem, and A. Dinc Immunopathogenesis of Behcet's disease with special emphasize on the possible role of antigen presenting cells Rheumatol Int 27 March (5) 2007 417 424
7. G. Hatemi, A. Silman, D. Bang, B. Bodaghi, A.M. Chamberlain, and A. Gul Management of Behcet's disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet's disease Ann Rheum Dis 68 October (10) 2009 1528 1534 [Research Support, Non-U.S. Govt Review]
8. G. Mumcu, T. Ergun, N. Inanc, I. Fresko, T. Atalay, and O. Hayran Oral health is impaired in Behcet's disease and is associated with disease severity Rheumatology (Oxford) 43 August (8) 2004 1028 1033
9. G. Mumcu Behcet's disease: a dentist's overview Clin Exp Rheumatol 26 July-August (4 Suppl. 50) 2008 S121 S124 [Review]
10. G. Mumcu, N. Inanc, S. Yavuz, and H. Direskeneli The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behcet's disease Clin Exp Rheumatol 25 July-August (4 Suppl. 45) 2007 S27 S33 [Review]
11. U. Karacayli, G. Mumcu, I. Simsek, S. Pay, O. Kose, and H. Erdem The close association between dental and periodontal treatments and oral ulcer course in Behcet's disease: a prospective clinical study J Oral Pathol Med 38 May (5) 2009 410 415 [Controlled Clinical Trial]
12. H. Direskeneli Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford) 45 12 2006 1461 1465 Epub 2006 Sep 23
13. E. Isogai, S. Ohno, S. Kotake, H. Isogai, T. Tsurumizu, and N. Fujii Chemiluminescence of neutrophils from patients with Behcet's disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora Arch Oral Biol 35 1 1990 43 48 [Research Support, Non-U.S. Gov't]
14. F. Kaneko, N. Oyama, H. Yanagihori, E. Isogai, K. Yokota, and K. Oguma The role of streptococcal hypersensitivity in the pathogenesis of Behcet's Disease Eur J Dermatol 18 September-October (5) 2008 489 498 [Review]
15. S. Hirohata, H. Oka, and Y. Mizushima Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet's disease Cell Immunol 140 April (2) 1992 410 419 [Research Support, Non-U.S. Gov't]
16. T. Miura, K. Ishihara, T. Kato, R. Kimizuka, H. Miyabe, and T. Ando Detection of heat shock proteins but not superantigen by isolated oral bacteria from patients with Behcet's disease Oral Microbiol Immunol 20 June (3) 2005 167 171
17. G. Mumcu, N. Inanc, S.Z. Aydin, T. Ergun, and H. Direskeneli Association of salivary S. mutans colonisation and mannose-binding lectin deficiency with gender in Behcet's disease Clin Exp Rheumatol 27 March-April (2 Suppl. 53) 2009 S32 S36
18. A. Van Nieuw Amerongen, J.G. Bolscher, and E.C. Veerman Salivary proteins: protective and diagnostic value in cariology? Caries Res 38 May-June (3) 2004 247 253
19. S. Gomes Pde, and M.H. Fernandes Defensins in the oral cavity: distribution and biological role J Oral Pathol Med 39 January (1) 2010 1 9
20. B.A. Dale, R. Tao, J.R. Kimball, and R.J. Jurevic Oral antimicrobial peptides and biological control of caries BMC Oral Health 6 Suppl. 1 2006 S13
21. R. Tao, R.J. Jurevic, K.K. Coulton, M.T. Tsutsui, M.C. Roberts, and J.R. Kimball Salivary antimicrobial peptide expression and dental caries experience in children Antimicrob Agents Chemother 49 September (9) 2005 3883 3888
22. B.A. Dale, and L.P. Fredericks Antimicrobial peptides in the oral environment: expression and function in health and disease Curr Issues Mol Biol 7 July (2) 2005 119 133
23. J.L. McLachlan, A.J. Sloan, A.J. Smith, G. Landini, and P.R. Cooper S100 and cytokine expression in caries Infect Immun 72 July (7) 2004 4102 4108
24. T. Kallinich, H. Wittkowski, R. Keitzer, J. Roth, and D. Foell Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever Ann Rheum Dis 69 April (4) 2010 677 682
25. Y. Niwa, and Y. Mizushima Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behcet's disease Clin Exp Immunol 79 March (3) 1990 353 360 [Research Support, Non-U.S. Gov't]
26. M. Takeno, A. Kariyone, N. Yamashita, M. Takiguchi, Y. Mizushima, and H. Kaneoka Excessive function of peripheral blood neutrophils from patients with Behcet's disease and from HLA-B51 transgenic mice Arthritis Rheum 38 March (3) 1995 426 433 [Research Support, Non-U.S. Gov't]
27. J. Kim, J.A. Park, E.Y. Lee, Y.J. Lee, Y.W. Song, and E.B. Lee Imbalance of Th17 to Th1 cells in Behcet's disease Clin Exp Rheumatol 28 July-August (4 Suppl. 60) 2010 S16 S19 [Research Support, Non-U.S. Gov't]
28. Criteria for diagnosis of Behcet's disease International Study Group for Behcet's Disease Lancet 335 5 May (8697) 1990 1078 1080
29. I. Krause, R. Mader, J. Sulkes, M. Paul, Y. Uziel, and M. Adawi Behcet's disease in Israel: the influence of ethnic origin on disease expression and severity J Rheumatol 28 May (5) 2001 1033 1036
30. O. Soehnlein Direct and alternative antimicrobial mechanisms of neutrophil-derived granule proteins J Mol Med 87 December (12) 2009 1157 1164
31. S. Kanmura, H. Uto, M. Numata, S. Hashimoto, A. Moriuchi, and H. Fujita Human neutrophil peptides 1-3 are useful biomarkers in patients with active ulcerative colitis Inflamm Bowel Dis 15 June (6) 2009 909 917
32. D.K.I. Mertens, I. Gunaydin, I. Fresko, H. Yazici, and C. Mueller Expression of α-defensins HNP-1 in Behçet's disease: effector molecules of spontaneous and pathergy induced papulopustular lesions? Clin Exp Rheumatol 22 Suppl. 34 2004 S-93
33. A. Baillet S100A8, S100A9 and S100A12 proteins in rheumatoid arthritis Rev Med Intern 2010 [April 14]
34. C. Goebel, L.G. Mackay, E.R. Vickers, and L.E. Mather Determination of defensin HNP-1, HNP-2, and HNP-3 in human saliva by using LC/MS Peptides 21 June (6) 2000 757 765
35. E. Phattarataratip, B. Olson, B. Broffitt, F. Qian, K.A. Brogden, and D.R. Drake Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides Mol Oral Microbiol 26 June (3) 2011 187 199 [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]
36. N. Mizukawa, K. Sugiyama, T. Ueno, K. Mishima, S. Takagi, and T. Sugahara Defensin-1 an antimicrobial peptide present in the saliva of patients with oral diseases Oral Dis 5 April (2) 1999 139 142